Tice Jeffrey A, Cummings Steven R, Smith-Bindman Rebecca, Ichikawa Laura, Barlow William E, Kerlikowske Karla
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143-1732, USA.
Ann Intern Med. 2008 Mar 4;148(5):337-47. doi: 10.7326/0003-4819-148-5-200803040-00004.
Current models for assessing breast cancer risk are complex and do not include breast density, a strong risk factor for breast cancer that is routinely reported with mammography.
To develop and validate an easy-to-use breast cancer risk prediction model that includes breast density.
Empirical model based on Surveillance, Epidemiology, and End Results incidence, and relative hazards from a prospective cohort.
Screening mammography sites participating in the Breast Cancer Surveillance Consortium.
1,095,484 women undergoing mammography who had no previous diagnosis of breast cancer.
Self-reported age, race or ethnicity, family history of breast cancer, and history of breast biopsy. Community radiologists rated breast density by using 4 Breast Imaging Reporting and Data System categories.
During 5.3 years of follow-up, invasive breast cancer was diagnosed in 14,766 women. The breast density model was well calibrated overall (expected-observed ratio, 1.03 [95% CI, 0.99 to 1.06]) and in racial and ethnic subgroups. It had modest discriminatory accuracy (concordance index, 0.66 [CI, 0.65 to 0.67]). Women with low-density mammograms had 5-year risks less than 1.67% unless they had a family history of breast cancer and were older than age 65 years.
The model has only modest ability to discriminate between women who will develop breast cancer and those who will not.
A breast cancer prediction model that incorporates routinely reported measures of breast density can estimate 5-year risk for invasive breast cancer. Its accuracy needs to be further evaluated in independent populations before it can be recommended for clinical use.
目前用于评估乳腺癌风险的模型很复杂,且未纳入乳腺密度这一乳腺癌的重要风险因素,而乳腺密度是乳腺钼靶检查中常规报告的内容。
开发并验证一种易于使用的包含乳腺密度的乳腺癌风险预测模型。
基于监测、流行病学和最终结果发病率以及前瞻性队列相对风险的实证模型。
参与乳腺癌监测联盟的乳腺钼靶筛查点。
1,095,484名接受乳腺钼靶检查且既往未诊断出乳腺癌的女性。
自我报告的年龄、种族或族裔、乳腺癌家族史以及乳腺活检史。社区放射科医生使用4种乳腺影像报告和数据系统类别对乳腺密度进行分级。
在5.3年的随访期间,14,766名女性被诊断为浸润性乳腺癌。乳腺密度模型总体校准良好(预期观察比为1.03[95%CI,0.99至1.06]),在种族和族裔亚组中也是如此。其具有适度的区分准确性(一致性指数为0.66[CI,0.65至0.67])。乳腺钼靶检查显示为低密度的女性,其5年风险低于1.67%,除非她们有乳腺癌家族史且年龄超过65岁。
该模型区分将患乳腺癌的女性和不会患乳腺癌的女性的能力有限。
一个纳入常规报告的乳腺密度测量指标的乳腺癌预测模型可以估计浸润性乳腺癌的5年风险。在推荐其用于临床之前,需要在独立人群中进一步评估其准确性。